Bruce Carrington

838 total citations
16 papers, 568 citations indexed

About

Bruce Carrington is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bruce Carrington has authored 16 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bruce Carrington's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Immune Response and Inflammation (4 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Bruce Carrington is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Immune Response and Inflammation (4 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Bruce Carrington collaborates with scholars based in United Kingdom, United States and Belgium. Bruce Carrington's co-authors include Alastair D. G. Lawson, Tim Bourne, Alistair J. Henry, Andrew G. Popplewell, James P. O’Connell, John Porter, David McMillan, Tom Ceska, David Fox and Abigail Lowe and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Molecular Biology.

In The Last Decade

Bruce Carrington

16 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce Carrington United Kingdom 14 301 194 133 90 44 16 568
Robert D. Hoffman United States 12 335 1.1× 49 0.3× 270 2.0× 57 0.6× 24 0.5× 18 706
Kenneth P. Karey United States 10 753 2.5× 151 0.8× 49 0.4× 148 1.6× 21 0.5× 15 1.0k
Maurice Mannesse Netherlands 13 441 1.5× 24 0.1× 161 1.2× 14 0.2× 21 0.5× 19 754
E J Beecham United States 7 389 1.3× 38 0.2× 146 1.1× 192 2.1× 9 0.2× 10 661
Min Ah Kang South Korea 9 292 1.0× 53 0.3× 53 0.4× 137 1.5× 8 0.2× 12 548
Prathap Kumar S. Mahalingaiah United States 12 314 1.0× 110 0.6× 47 0.4× 218 2.4× 4 0.1× 20 647
Shanshan Jiang China 16 333 1.1× 22 0.1× 48 0.4× 89 1.0× 31 0.7× 50 596
Ping Tang China 14 591 2.0× 29 0.1× 130 1.0× 159 1.8× 15 0.3× 25 862
J. Thomas Pento United States 14 300 1.0× 44 0.2× 39 0.3× 142 1.6× 8 0.2× 68 607

Countries citing papers authored by Bruce Carrington

Since Specialization
Citations

This map shows the geographic impact of Bruce Carrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Carrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Carrington more than expected).

Fields of papers citing papers by Bruce Carrington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Carrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Carrington. The network helps show where Bruce Carrington may publish in the future.

Co-authorship network of co-authors of Bruce Carrington

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Carrington. A scholar is included among the top collaborators of Bruce Carrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Carrington. Bruce Carrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
McMillan, David, C. Martinez-Fleites, John Porter, et al.. (2021). Structural insights into the disruption of TNF-TNFR1 signalling by small molecules stabilising a distorted TNF. Nature Communications. 12(1). 582–582. 63 indexed citations
2.
Lightwood, Daniel, John Porter, David McMillan, et al.. (2021). A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNF. Nature Communications. 12(1). 583–583. 22 indexed citations
3.
O’Connell, James P., John Porter, Stephen Rapecki, et al.. (2019). Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer. Nature Communications. 10(1). 5795–5795. 81 indexed citations
4.
Liu, Xiaofeng, et al.. (2018). The rational design of affinity-attenuated OmCI for the purification of complement C5. Journal of Biological Chemistry. 293(36). 14112–14121. 10 indexed citations
5.
Carrington, Bruce, William K. Myers, P.S. Horanyi, Mark Calmiano, & Alastair D. G. Lawson. (2017). Natural Conformational Sampling of Human TNFα Visualized by Double Electron-Electron Resonance. Biophysical Journal. 113(2). 371–380. 11 indexed citations
6.
Hall, Catherine J., Václav Veverka, Frederick W. Muskett, et al.. (2014). Conformational Heterogeneity in Antibody-Protein Antigen Recognition. Journal of Biological Chemistry. 289(10). 7200–7210. 14 indexed citations
7.
Shaw, Stevan, Tim Bourne, Chris Meier, et al.. (2014). Discovery and characterization of olokizumab. mAbs. 6(3). 773–781. 70 indexed citations
8.
Wolff, Christian, Bruce Carrington, Michel Varrin‐Doyer, et al.. (2012). Drug Binding Assays do not Reveal Specific Binding of Lacosamide to Collapsin Response Mediator Protein 2 (CRMP‐2). CNS Neuroscience & Therapeutics. 18(6). 493–500. 32 indexed citations
9.
Lightwood, Daniel, Victoria O’Dowd, Bruce Carrington, et al.. (2012). The Discovery, Engineering and Characterisation of a Highly Potent Anti-Human IL-13 Fab Fragment Designed for Administration by Inhalation. Journal of Molecular Biology. 425(3). 577–593. 30 indexed citations
10.
Veverka, Václav, Terry Baker, Nicholas T. Redpath, et al.. (2012). Conservation of Functional Sites on Interleukin-6 and Implications for Evolution of Signaling Complex Assembly and Therapeutic Intervention. Journal of Biological Chemistry. 287(47). 40043–40050. 23 indexed citations
11.
Humphreys, David P., Sam Heywood, Alistair J. Henry, et al.. (2007). Alternative antibody Fab′ fragment PEGylation strategies: combination of strong reducing agents, disruption of the interchain disulphide bond and disulphide engineering. Protein Engineering Design and Selection. 20(5). 227–234. 37 indexed citations
12.
Lightwood, Daniel, Bruce Carrington, Alistair J. Henry, et al.. (2006). Antibody generation through B cell panning on antigen followed by in situ culture and direct RT-PCR on cells harvested en masse from antigen-positive wells. Journal of Immunological Methods. 316(1-2). 133–143. 19 indexed citations
13.
Turner, Christopher T., Neil Weir, Catherine Catterall, et al.. (2002). THE TRANSFECTION OF JURKAT T-LEUKEMIC CELLS BY USE OF PH-SENSITIVE IMMUNOLIPOSOMES. Journal of Liposome Research. 12(4). 311–334. 14 indexed citations
14.
Humphreys, David P., Bruce Carrington, Bryan John Smith, et al.. (2002). A plasmid system for optimization of Fab′ production in Escherichia coli: importance of balance of heavy chain and light chain synthesis. Protein Expression and Purification. 26(2). 309–320. 39 indexed citations
15.
Smith, Bryan John, Andrew G. Popplewell, Andrew P. Chapman, et al.. (2001). Prolonged in Vivo Residence Times of Antibody Fragments Associated with Albumin. Bioconjugate Chemistry. 12(5). 750–756. 61 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert D. Hoffman Breakdown of academic impact, for papers by Kenneth P. Karey Breakdown of academic impact, for papers by Maurice Mannesse Breakdown of academic impact, for papers by E J Beecham Breakdown of academic impact, for papers by Min Ah Kang Breakdown of academic impact, for papers by Prathap Kumar S. Mahalingaiah Breakdown of academic impact, for papers by Shanshan Jiang Breakdown of academic impact, for papers by Ping Tang Breakdown of academic impact, for papers by J. Thomas Pento
Rankless by CCL
2026